Synergy Pharmaceuticals Catches Eyes: Stock Jumps 8.6% - Tale of the Tape
December 24 2013 - 8:44AM
Zacks
Synergy Pharmaceuticals,
Inc. (SGYP) was a big mover last session, as the company
saw its shares rise nearly 9% on the day. This jump can be
attributable to solid volume too with far more shares changing
hands than in a normal session. This continues the recent uptrend
for the company, as the stock has risen about 12% since Dec 11.
Over the last 30 days, Synergy Pharmaceuticals did not witness any
estimate revision and the Zacks Consensus Estimate has remained
unchanged. However, the recent price action is encouraging, so make
sure to keep a close watch on this firm in the near future.
Synergy Pharmaceuticals currently has a Zacks Rank #2 (Buy) while
its Earnings ESP is 0.00%.
Some better-ranked stocks in the healthcare industry include
Heska Corporation (HSKY), Questcor
Pharmaceuticals, Inc. (QCOR) and Forest
Laboratories Inc. (FRX), each with a Zacks Rank #1 (Strong
Buy).
Want the latest recommendations from Zacks Investment Research?
Today, you can download 7 Best Stocks for the Next 30
Days. Click to get this free report >>
FOREST LABS A (FRX): Free Stock Analysis Report
HESKA CORP (HSKA): Free Stock Analysis Report
QUESTCOR PHARMA (QCOR): Free Stock Analysis Report
SYNERGY PHARMAC (SGYP): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Forest Road Acquisition (NYSE:FRX)
Historical Stock Chart
From Sep 2024 to Oct 2024
Forest Road Acquisition (NYSE:FRX)
Historical Stock Chart
From Oct 2023 to Oct 2024